tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Imricor Options Lapse, Slightly Simplifying Capital Structure

Story Highlights
  • Imricor Medical Systems Inc., an ASX-listed cardiac-focused medtech firm, holds various classes of securities including listed options.
  • The company reported that 52,500 IMRAJ options lapsed on 1 January 2026, modestly reducing potential dilution and simplifying capital structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Imricor Options Lapse, Slightly Simplifying Capital Structure

Claim 50% Off TipRanks Premium

An announcement from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) is now available.

Imricor Medical Systems Inc., an ASX-listed medical technology company focused on cardiac-related products, maintains its issued capital structure through various classes of securities, including options listed under the code IMRAJ. The company has notified the market that 52,500 IMRAJ options, which were subject to various exercise prices and expiry dates, have lapsed effective 1 January 2026 because the conditions for exercising these rights were not met or had become incapable of being satisfied, resulting in a modest reduction in potential future dilution for existing shareholders and a slight simplification of the company’s capital structure.

The most recent analyst rating on (AU:IMR) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.

More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Imricor Medical Systems Inc. is a medical technology company listed on the ASX that develops products for cardiac procedures, with its securities traded under the issuer code IMR.

Average Trading Volume: 205,913

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$506.3M

Find detailed analytics on IMR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1